FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Reporters Urged to Probe FDA Transparency

[ Price : $8.95]

The Association of Health Care Journalists urges its journalist members to look deeper into FDAs use of advisory committees in its...

Calcium Carbonate OK for Use in Supplements

[ Price : $8.95]

Federal Register final rule: FDA amends the color additive regulations to allow calcium carbonates use in dietary supplement table...

Guide on Pediatric Study Ethical Considerations

[ Price : $8.95]

Federal Register notice: FDA posts a draft guidance entitled Ethical Considerations for Clinical Investigations of Medical Product...

New Regulatory Paradigm Needed for Device Software: FDA

[ Price : $8.95]

FDA concludes after ending a recent pilot program on software as a medical device that a new regulatory paradigm is needed to regu...

3 Biocon Biologics FDA-483s Posted

[ Price : $8.95]

FDA posts three Form FDA-483s issued to Indias Biocon Biologics following three on-site August inspections at the companys seven m...

OGD Director Choe Leaving FDA Next Month

[ Price : $8.95]

CDER Office of Generic Drugs director Sally Choe decides to leave FDA effective 10/8 to pursue opportunities outside the agency.

CDER Adds Cannabis Advisor in Directors Office

[ Price : $8.95]

Former New York cannabis programs director Norman Birenbaum joins CDERs Office of the Center Director as a senior public health ad...

Guide on Exclusions for Naloxone Distribution

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Exemption and Exclusion from Certain Requirements of the Dr...

Regulatory Review Period for Nurtec ODT

[ Price : $8.95]

Federal Register FDA determines for patent extension purposes the regulatory review period for Biohaven Pharmaceuticals migraine d...

Info Collection on Pediatric Device Survey

[ Price : $8.95]

Federal Register notice: FDA seeks comments on a new information collection involving a pediatric device survey.